Search

everythinglearnresearchcommunity

for

Search:↓

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Platelet-rich plasma treatment significantly increased hair diameter and density, stopped hair fall, and boosted hair growth in men with hair loss, with no reported side effects.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Moderately high prolactin levels do not cause hair loss in women.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

The study concluded that hair loss treatments should be tailored to the specific type of alopecia and individual patient needs.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.